Foresight Diagnostics Launches PRECISE-HL Trial to Explore ctDNA-Based Therapy De-Escalation in Classical Hodgkin Lymphoma (cHL)
Foresight Diagnostics, which provides ultra-sensitive minimal residual disease (MRD) detection technology, today announced the launch of the PRECISE-HL clinical trial with the University of Washington ...
Medscape9h
Tislelizumab Receives First-Line Nod for Unresectable/Metastatic ESCC
The US Food and Drug Administration has approved tislelizumab (Tevimbra, BeiGene), in combination with platinum-containing ...
Armed robbery in Revesby10h
Biomarkers Found to Enhance Endometrial Cancer Care
Researchers at the Icahn School of Medicine at Mount Sinai have made an important discovery that could help doctors choose ...
Targeted Oncology18h
Biomarkers Have Potential to Shape Treatment of RCC
Alan Tan, MD, discusses potential biomarkers that are being investigated to optimize treatment of patients with renal cell ...
Newly discovered biomarkers could improve endometrial cancer treatment
Researchers at the Icahn School of Medicine at Mount Sinai have made an important discovery that could help doctors choose ...
Merkel Cell Carcinoma Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies
The leading Merkel Cell Carcinoma Companies such as ImmunityBio, OncoSec Medical, Exelixis, 4SC, Kartos Therapeutics, Incyte ...
Microbiome Disease Clinical Trial Analysis: Key Insights Into Rich Pipeline Featuring 140+ Companies And 180+ Therapies | Delveinsight
The potential of the microbiome in disease treatment and prevention is an emerging and highly promising field in medicine. Research into microbiome-b ...